Quest Laboratories Limited — Important, 31-01-2025: General Updates

Quest Laboratories has provided a positive business update for the nine months ending December 31, 2024. Revenue for this period reached ₹67.15 Crores, reflecting solid performance despite a decline compared to the previous fiscal year. The company is on track for significant growth, aiming for a projected revenue of ₹110 to ₹115 Crores, indicating a potential growth rate of 70-75% for FY25.

The company is advancing its manufacturing capabilities with two new facilities under development. A new capsule production facility is expected to begin operations by the end of 2025, contributing ₹10-15 Crores in annual revenue, while an advanced injectable section set to launch in March 2026 is projected to generate ₹30-35 Crores annually.

Internationally, Quest Laboratories is registering products in new markets, including Myanmar, where they have a secured order book of ₹25 Crores. The company aims to grow its exports significantly over the next two years. These strategic moves enhance its potential for sustained growth and value creation for investors.